Categories
World News

Stagflation is the best danger to Europe’s restoration

Former Italian Prime Minister Mario Monti told CNBC on Saturday that he believed the greatest threat to Europe’s economic recovery from the coronavirus pandemic was “stagflation”.

Monti, now president of Bocconi University in Italy, said the “huge bulk” of central banks’ expansionary monetary policies and government fiscal incentives put in place to support economies amid the coronavirus pandemic “could well trigger more inflation.”

At the same time, Monti said there were “a number of restrictions on the flexibility of production” that needed to be increased.

Generally speaking, stagflation is when the rate of inflation is high, but economic growth is slowing and unemployment continues to rise.

The IHS Markit Flash Composite purchasing managers’ index for the euro zone, which tracks activity in manufacturing and services, hit a two-month low of 59.5 in August, compared with 60.2 in July. A value above 50 still means that economic activity is expanding, but many economists have suggested that dynamism in the region may slow down.

Former Italian Prime Minister Mario Monti will perform on “Porta a Porta” on October 11, 2018 in Rome, Italy.

Massimo Di Vita | Massimo Di Vita Archive | Mondadori portfolio | Getty Images

There are also concerns about the impact of supply chain problems from Asia affecting manufacturing in Europe, as well as the fact that higher wages could lead to inflationary pressures.

Speaking to CNBC’s Steve Sedgwick at the European House Ambrosetti Forum on Saturday, Monti said that economies, not just in the EU, may begin to experience elements of “stagflation”, similar to what happened in many countries in the 1970s.

As a result, Monti said it was “very important to manage this transition from a needed abundance of financial and financial support to a simpler situation with caution and in a coordinated manner.”

Preliminary data released on Tuesday showed that inflation in the eurozone hit a 10-year high in August, with consumer prices up 3% year over year.

The European Central Bank will hold its next policy meeting on September 9th to discuss the way forward for its asset purchase program. However, analysts told CNBC earlier this week that they expect the ECB to suspend its announcement of tapering its Covid stimulus measures until December.

– CNBC’s Silvia Amaro contributed to this report.

Categories
World News

Europe’s journey trade determined as Covid surges

In 2020, workers will carry scaffolding on the beach “Paradise” on the Greek Cycladic island of Mykonos. The island has traditionally been overcrowded with wealthy foreigners, but it turned into a ghost island last year.

ARIS MESSINIS | AFP | Getty Images

During the Covid-19 pandemic, perhaps no other industry was hit harder than the global travel and tourism sector, as planes grounded, resorts closed, and carefree vacations are a distant memory for most of us.

Some countries in Europe – Greece, Spain, and Portugal, for example – rely on tourism to fuel economic growth, with the prosperity of thousands of businesses, livelihoods, and communities tied to the success or failure of the season.

With Covid vaccinations rolled out across the region since late 2020, there were high hopes that Europe could look forward to a recovery in summer tourism this year.

Instead, the season looks very uncertain, as the delta variant is increasing in Europe and stipulating a multitude of different rules and restrictions, traffic light systems, country risk profiles as well as possible quarantines and entry requirements for vaccines.

Fourth wave?

Traveling within Europe these days is in many ways not for the faint of heart. The Covid infection rate has increased across the region as the highly contagious Delta variant has conquered the globe.

As with the previous Alpha variant (which Delta has now usurped), the UK was something of a harbinger of doom when it came to what the rest of Europe could expect. The UK saw another wave of Covid caused by the alpha variant earlier this year and is now seeing another wave with Delta.

Despite efforts on the continent to contain the variant, the inevitable spread has occurred, with the strain now accounting for the majority of new infections from country to country.

The Netherlands and Spain have seen large spikes in cases, largely due to the night sector, after both countries reopened their nightclubs in late June, only to reverse course two weeks later. Meanwhile, France announced earlier this week that it was entering a fourth wave of the pandemic, with government spokesman Gabriel Attal sounding the alarm:

“We have entered a fourth wave. The epidemic dynamics are extremely strong. We are seeing a faster wave and a bigger surge than any previous … the incidence rate continues to explode … So big, so sudden, we have that not seen since the beginning of the pandemic, “said Attal on Monday.

Tourism and airline stocks took a hit earlier this week as global markets slumped on renewed fears about the global recovery. EasyJet and Ryanair, well-known low-cost airlines in Europe, were among the stocks that posted significant price losses. EasyJet’s shares, for example, traded at 842.20 pence on Friday but fell to 758.20 pence early Monday afternoon.

Easyjet CEO Johan Lundgren told CNBC on Tuesday that the travel sector was facing an “extremely challenging” situation, but that vaccination programs in Europe were key to reopening. The data shows that two doses from Pfizer-BioNTech or AstraZeneca-Oxford University are effective against the Delta variant, reducing the risk of hospitalization and death.

“We always knew that [the recovery] shouldn’t be a straight line … But we see the restrictions lifted. But it is absolutely right that when you open up societies and communities, infections also increase. The question is whether the vaccinations make the link between [infection and] severe hospitalization and death, and luckily it looks like it, “Lundgren told CNBC’s Squawk Box Europe.

Complex trips

Anyone planning a last-minute European vacation this year should expect an often confusing, complex, and quite stressful experience – even before you get off the plane.

As a general example of the complexities of vacationing in these troubled times, let’s take traveling from the UK to Greece – a vacation that 3.4 million Britons took in 2019, as official statistics show:

Greece allows UK visitors if they can provide evidence of a negative Covid-19 PCR test performed within 72 hours of arriving in the country or evidence of a negative rapid antigen test performed by an authorized laboratory within the 48 hour before the scheduled flight; or proof of two doses of a Covid vaccine completed at least 14 days prior to travel.

Before entering Greece, however, you must fill out a passenger search form with your vaccination status, your vacation address and the next of kin no later than 11:59 p.m. (local time) the previous day. Then vacationers must take a PCR test and fill out another passenger locator form before returning to the UK, and then have another PCR test or 10 day quarantine within two days of their return to the UK.

All of that, and Greece is actually one of the easier places to vacation this year.

Like its fellow Europeans, Greece has not escaped the somewhat inevitable spike in Covid cases as the economy (especially the island’s night economy) has opened up. Still, the daily number of cases seems small compared to France or the UK. On Wednesday, Greece reported 2,972 new cases, 19 of which were located after controls at the country’s borders.

Busier times in Paliouri Beach, Greece: this picture was taken in 2017 which was considered one of the busiest summers in terms of visitor arrivals.

NurPhoto | NurPhoto | Getty Images

Wolfango Piccoli, co-president of the Teneo Intelligence risk advisory service, stated on Wednesday that the resurgence of Covid-19 in Greece “brings with it new challenges, particularly with regard to another lean tourist season and the following economic consequences”, circumstances that Put pressure on Prime Minister Kyriakos Mitsotakis.

“Mitsotakis had hoped to leave the pandemic behind this summer when his center-right government reached the middle of its four-year return to growth. However, the Covid-19 numbers have risen significantly in recent weeks and the important tourism sector is already pushing for more government support in the fall, fearing that visitor numbers will be even more disappointing this year, “said Piccoli.

As the Delta variant gradually became more dominant, Piccoli noted that Greece was puzzled as “the number of daily vaccinations has fallen below 100,000 this month, despite the government incentivizing Greeks between the ages of 18 and 25 150 euros (177 US dollars) offers vaccinated. “

So far, only about 120,000 of an estimated 980,000 Greeks in this age group have been vaccinated.

Immunization rates in the general population have reached nearly 52% for at least one dose of the vaccine and nearly 44% for full vaccination, Piccoli noted, adding that “the recent slower uptake has cast doubt on the government’s ability to meet its vaccination goal.” 70-75% of the adult population by the end of summer. “

Categories
Health

Austrian startup GoStudent turns into Europe’s first edtech unicorn

School children in the Netherlands doing homework at home during the coronavirus crisis.

Robin Utrecht | SOPA Images | LightRocket via Getty Images

LONDON — SoftBank, Tencent and other leading investors are betting that the next big online education company will come out of Europe.

Vienna-based online tutoring start-up GoStudent said Tuesday that it raised 205 million euros ($244 million) in a bumper investment round that values the five-year-old firm at 1.4 billion euros, or about $1.67 billion.

According to CB Insights data, that means GoStudent is Europe’s first education technology — or edtech — unicorn, a start-up with a valuation of at least $1 billion. Though Norwegian rival Kahoot hit a billion-dollar valuation last year, it doesn’t technically count as it has been publicly listed since October 2019.

GoStudent was founded in 2016 by Austrian entrepreneur Felix Ohswald, who was inspired by practical math lessons from his grandfather before he even started school.

“He had this ability to teach you that stuff in a way that was very applicable,” Ohswald told CNBC, referring to his grandfather.

“One of the biggest problems in education is lack of access to great teachers,” he added.

What is GoStudent?

GoStudent is an online service that connects students between the ages of six to 19 with private tutors. The company sells monthly tutoring subscriptions to parents, taking a cut from the tutors’ earnings as commission. GoStudent session prices range from 17.50 euros to 26.90 euros — between $20 to $32 — per month.

Ohswald, who completed his bachelor’s degree in math at the age of 18, said his firm is now selling 400,000 sessions a month, and sales have grown 700% over the last 12 months. GoStudent aims to double the number of monthly sessions on its platform to 800,000 by the end of 2021.

The mindset for online teaching as a whole completely changed.

Felix Ohswald

founder, GoStudent

Edtech companies like Coursera, 2U and Chegg boomed during the coronavirus pandemic as lockdown restrictions pushed 1.5 billion children around the world into remote learning. However, Ohswalt said Covid-19 school closures actually led to a reduction in demand for “supplemental” teaching services like GoStudent.

“On the other hand, the mindset for online teaching as a whole completely changed,” he added. “Suddenly, parents extremely skeptical about online learning before the pandemic now at least give it a chance and try it out.”

GoStudent says it vets all tutors on its website, with Ohswalt describing the application process as “pretty tough.” Just 8% of math tutor applicants succeed in being accepted to run lessons on GoStudent, he said.

But GoStudent was embroiled in controversy earlier this year after it emerged that a 60-year-old who was banned from teaching, because he sold naked pictures of himself to a teenager, was providing lessons on the platform. GoStudent said the teacher gave a fake name and was removed from its service after the company became aware.

Expansion plans

GoStudent’s fresh cash infusion was led by DST Global, an investor in the likes of retail trading app Robinhood and fintech firm Revolut. SoftBank’s Vision Fund 2, Tencent, Dragoneer and existing investors including Coatue also backed the round.

Having raised a total of 291 million euros to date, GoStudent plans to expand beyond Europe — where it has a presence in 15 countries — to other markets like Mexico and Canada by the summer.

Asia is another potential geographic expansion target for the firm, Ohswald said, highlighting the Philippines, Indonesia and Malaysia as “interesting” opportunities. However, he ruled out an expansion into countries like China and India, which are already home to established e-learning players such as Yuanfudao and Byju’s.

GoStudent said it would ramp up hiring and aimed to nearly double its global workforce from 600 employees to 1,000 by year-end. Part of the funding may also be used for acquisitions, the firm said.

Categories
Business

Europe’s Economic system Shrank in First Quarter, Revealing a Recession: Reside Updates

Here’s what you need to know:

Credit…Alessandro Grassani for The New York Times

The eurozone economy contracted by 0.6 percent over the first three months of the year, sliding back into recession, as the still-raging pandemic prompted governments to extend lockdowns.

Coming a day after the United States disclosed that its economy expanded 1.6 percent over the same period, the European downturn presented a contrast of fortunes on opposite sides of the Atlantic.

Propelled by dramatic public expenditures to stimulate growth, as well as swift increases in vaccination rates, the United States — the world’s largest economy — expanded rapidly during the first months of 2021. At the same time, the 19 nations that share the euro currency were caught in the second part of a so-called double-dip recession, reflecting far less aggressive stimulus spending and a botched effort to secure vaccines.

But figures for gross domestic product represent a snapshot of the past, and recent weeks have produced encouraging signs that Europe is on the mend. The alarming spread of Covid-19 in major economies like Germany and France has begun to trend downward, factories have revived production, while growing numbers of people are on the move in cities.

Even as the German economy diminished by 1.7 percent from January to March, Italy and Spain slipped by much smaller magnitudes — 0.4 percent and 0.5 percent respectively. The French economy grew by a modest 0.4 percent, though its prospects face a fresh challenge in the form of new pandemic restrictions imposed this month by the government.

The initial lockdowns last year punished Europe’s economies, bringing large swaths of commercial life to a halt. But the current restrictions are calibrated to reflect improved understanding of how the virus spreads. Rather than closing their doors altogether, restaurants in some countries are serving meals on patios and dispensing takeout orders. Roofers, carpenters and other skilled trades have resumed work, so long as they can stay outside.

“We have sort of learned to live with the pandemic,” said Dhaval Joshi, chief strategist at BCA Research in London. “We are adapting to it.”

Vaccination rates are increasing throughout Europe, a trend likely to be advanced by the European Union’s recent deal to secure doses from Pfizer.

Most economists and the European Central Bank expect the eurozone to expand at a blistering pace over the rest of 2021, yielding growth of more than 4 percent for the full year.

Still, even in the most hopeful scenario, Europe’s recovery is running behind the United States, a reflection of their differing approaches to economic trauma.

Since last year, the United States has unleashed additional public spending worth 25 percent of its national economic output for pandemic-related stimulus and relief programs, according to the International Monetary Fund. That compares to 10 percent in Germany.

But Europe also began the crisis with far more comprehensive social safety net programs. While the United States directed cash to those set back by the pandemic, Europe limited a surge in unemployment.

“Europe has more insurance schemes,” said Kjersti Haugland, chief economist at DNB Markets, an investment bank in Oslo. “You don’t fall as hard, but you don’t rebound that sharply either.”

Exxon reported a $2.7 billion profit in the first three months of the year, thanks to rising production and higher chemical prices.Credit…Lee Celano/Reuters

Exxon Mobil and Chevron, the two biggest oil companies in the United States, on Friday reported their first quarterly profits after several quarters of losses, signaling that the energy industry is rebounding from the coronavirus pandemic.

Oil prices have climbed in recent months and are now roughly where they were before the pandemic’s full force was felt. As a result, Exxon reported a $2.7 billion profit in the first three months of the year, compared with a loss of $610 million in the same period a year ago. Chevron said its profit was $1.4 billion, down from $3.6 billion a year earlier. Chevron this week raised its dividend by nearly 4 percent.

The American oil benchmark price, now around $64 a barrel, has tripled since last April. Natural gas prices have also strengthened during the recovery.

“The strong first quarter results reflect the benefits of higher commodity prices and our focus on structural cost reductions,” Darren Woods, Exxon’s chief executive, said in a statement.

Only six months ago, many analysts warned that Exxon would have to cut its dividend, but now the shareholder payout appears safe because of rising production and higher chemical prices. Exxon this month reported yet another in a string of big oil discoveries off the coast of Guyana, one of its most important growth areas.

At Chevron, sales and other revenue in the quarter increased to $31 billion, $1 billion more than the year-ago quarter.

“Earnings strengthened primarily due to higher oil prices as the economy recovers,” said Mike Wirth, Chevron’s chief executive.

Both companies suffered losses from the severe Texas freeze in February. Exxon reported that lost sales and repairs cost the company nearly $600 million. Chevron said its results were weakened by $300 million in lost oil and refining production and repairs.

Volkswagen wanted to have a little fun when it introduced the all-electric ID.4 to the United States in March. The Securities and Exchange Commission wasn’t laughing.Credit…Bryan Derballa for The New York Times

Volkswagen’s American unit was only kidding when it put out the word late in March that it was changing its name to “Voltswagen” to show its commitment to electric vehicles. To say the April Fool’s joke didn’t land is an understatement. Now the misfired marketing gag has prompted an inquiry by the Securities and Exchange Commission.

Volkswagen did not dispute reports in Der Spiegel and other German media that the S.E.C. was looking into whether the carmaker misled shareholders with the faux rebranding. Volkswagen in Germany declined to comment Friday.

Publicly listed companies are not supposed to fool their shareholders, even in jest. Some media reported the purported name change as fact until Volkswagen of America admitted it was all a joke.

German law also requires companies to be honest with their shareholders, but a spokeswoman for the stock market regulator, known as Bafin, said the agency saw no basis to investigate the Voltswagen issue.

It is unlikely that Volkswagen will face a serious penalty if the S.E.C. finds a violation, at least not compared to the tens of billions of dollars that an emissions scandal has cost the company since 2015. The gag does not appear to have had any influence on the price of Volkswagen shares, which rose for several days even after the company admitted it was all a ruse.

Like a comedian bombing onstage, the most painful consequence may be the humiliation.

Comments from Marin. J. Wash, the labor secretary, on gig workers sent shares of Uber, Lyft, Fiverr and DoorDash down sharply.Credit…Pool photo by Pat Greenhouse/EPA, via Shutterstock

Martin J. Walsh, the labor secretary, said on Thursday that “in a lot of cases” gig workers in the United States should be classified as employees, not independent contractors. “In some cases they are treated respectfully and in some cases they are not, and I think it has to be consistent across the board,” he told Reuters.

Shares of Uber, Lyft, Fiverr and DoorDash fell sharply on the news. These companies’ business models depend on classifying workers as independent contractors, who are not entitled to labor protections like a minimum wage or overtime pay.

But how much control does Mr. Walsh have over how companies classify their employees?

There’s no single law that makes workers employees or contractors. The Labor Department can enforce the Fair Labor Standards Act, which establishes the federal minimum wage and overtime pay. This law applies only to employees, and who should fall into that category has been the subject of a long-running debate.

In 2015, the Obama administration issued guidance that many interpreted to mean that app-based workers should be considered employees. It was rescinded by the Trump administration.

In 2021, the Trump administration issued a rule that would have made it easier for the same companies to classify workers as contractors. It was nixed by the Biden administration. Mr. Walsh’s comments suggest his interpretation will be similar to the Obama administration’s. And David Weil, reportedly President Biden’s nominee to lead the Labor Department’s wage and hour division, wrote the 2015 guidance.

New guidance wouldn’t change the law, but it could change how the Labor Department decides whether to bring lawsuits against gig economy companies. “It’s implicitly a sign to employers that you should comply with this interpretation or there’s a risk of enforcement,” Brian Chen, a staff attorney at the National Employment Law Project, told the DealBook newsletter.

Although such guidance is nonbinding, Benjamin Sachs, a professor at Harvard Law School, said courts “tend to give it deference” when making decisions. “I wouldn’t be surprised if we saw specific action coming from the department sometime this year,” said William Gould, a Stanford law professor and the former chairman of the National Labor Relations Board.

Ari Emanuel, the chief executive of the entertainment conglomerate Endeavor. “We’re platform agnostic, and we serve all parties,” he said of the streaming wars.Credit…Shannon Stapleton/Reuters

The Endeavor Group, the entertainment conglomerate run by the Hollywood mogul Ari Emanuel, pulled its initial public offering at the last minute in 2019, amid lukewarm interest from investors. Last year posed its own difficulties, with a pandemic that hurt its live events business as well as its talent agency.

But Endeavor finally made its market debut on Thursday, closing the day with a market cap of more than $10 billion. Mr. Emanuel spoke with the DealBook newsletter about what changed — and what comes next.

On why the I.P.O. went ahead this time:

“There was confusion with regard to the U.F.C., so we cleaned that up,” Mr. Emanuel said about the mixed-martial arts league that Endeavor is acquiring full control of with proceeds from the offering. Debt was also a worry before, and the company’s leverage will be reduced with help from a $1.7 billion private placement, with Third Point and Elliot Management among the investors. S&P Global upgraded the company’s credit rating on Thursday.

Endeavor also used the pandemic period to restructure and consolidate, shifting further away from its talent agency roots. And Mr. Emanuel expects its events business, entertainment relationships and intellectual property will help feed a demand for “content in all forms” after the pandemic: “We’re the story about coming out.”

On Endeavor’s role in the streaming wars:

“We’re platform agnostic, and we serve all parties,” Mr. Emanuel said. The broadcasters are spending “huge” amounts to build out their streaming platforms. “I don’t have to do that,” he said. “I just have to supply it.”

On how he met Elon Musk, who is joining Endeavor’s board:

“I definitely cold called. That’s kind of in my nature,” Mr. Emanuel said. “We’ve represented him in some of his endeavors. And then over time, he and I became friendly.”

“He’s also a great entrepreneur, meaning he knows how hard it is to build and run a company,” he added, noting that they often call each other for advice.

On whether he has any concerns about putting Mr. Musk on the board given the Tesla chief’s run-ins with securities regulators:

“No.”

Receiving the AstraZeneca vaccine in Budapest.Credit…Akos Stiller for The New York Times

The vaccine developed by AstraZeneca and the University of Oxford brought in $275 million in sales from about 68 million doses delivered in the first three months of this year, AstraZeneca reported on Friday.

AstraZeneca disclosed the figure, most of which came from sales in Europe, as it reported its first-quarter financial results. It offers the clearest view to date of how much money is being brought in by one of the leading Covid vaccines.

AstraZeneca, which has pledged not to profit on its vaccine during the pandemic, has been selling the shot to governments for several dollars per dose, less expensive than the other leading vaccines. The vaccine has won authorization in at least 78 countries since December but is not approved for use in the United States.

The vaccine represented just under 4 percent of AstraZeneca’s revenue for the quarter; it was nowhere near the company’s biggest revenue generator. By comparison, the company’s best-selling product, the cancer drug Tagrisso, brought in more than $1.1 billion in sales in the quarter.

AstraZeneca has said it is planning to seek emergency authorization for its vaccine to be used in the United States, even as it has become clear that the doses are not needed. The Biden administration said this week that it would make available to the rest of the world up to 60 million doses of its supply of AstraZeneca shots, pending a review of their quality.

If the company does win authorization from the U.S. Food and Drug Administration, it could help shore up confidence in a vaccine whose reputation been hit by concerns about a rare but serious side effect involving blood clotting. The F.D.A.’s evaluation process is considered the gold standard globally.

Johnson & Johnson, whose vaccine was authorized for emergency use at the end of February, reported last week that its vaccine generated $100 million in sales in the United States in the first three months of the year. The federal government is paying the company $10 a dose. Like AstraZeneca, Johnson & Johnson has pledged to sell its vaccine “at cost” — meaning it won’t profit on the sales — during the pandemic.

Vaccines from Pfizer and Moderna cost more, and neither company has said that it will forego profits. Pfizer has said that it expects its vaccine to bring in about $15 billion in revenue this year; Moderna said it anticipates $18.4 billion in sales.

Both companies are scheduled to report their first-quarter results next week.

By: Ella Koeze·Data delayed at least 15 minutes·Source: FactSet

U.S. stocks fell in early trading on Friday, with the S&P 500 pulling back from a record high reached the day before, as traders closed positions for the end of the month and continued to react to company earnings.

Despite Friday’s decline, the S&P 500 is still on track for a gain of about 5 percent for April, its best monthly showing since November — when stocks rallied nearly 11 percent in the wake of the U.S. presidential election.

The benchmark stock index had hit a record after data showed the American economy grew strongly at the start of the year. Forecasters predict the economy will be back to its prepandemic size by the summer and will help drive global economic growth.

Oil prices fell, with futures on West Texas Intermediate, the U.S. benchmark, dropping more than 2 percent to $63.50 a barrel.

  • The Stoxx Europe 600 index was slightly lower. The index is heading for a second consecutive week of losses, which hasn’t happened since October.

  • The eurozone economy contracted by 0.6 percent over the first three months of the year, sliding back into recession, as the pandemic prompted governments to extend lockdowns. The decline was smaller than economists surveyed by Bloomberg had forecast, but it still puts much of Europe in a double-dip recession.

  • AstraZeneca rose 3.4 percent in London after the drugmaker’s first-quarter earnings beat analysts expectations. The company also said that the vaccine it developed with the University of Oxford brought in $275 million in sales from about 68 million doses in the first three months of the year; the company has pledged not to profit from the vaccine.

  • Barclays shares plunged 6 percent after what the bank’s chief executive described as a “mixed result” for its first-quarter earnings. Income from trading in equities rose but fell for other assets. Still, the bank has a sunny outlook for the future. Jes Staley, the chief executive, said he expected the British economy to grow at the fastest pace since 1948.

  • Twitter shares dropped 13 percent after the social media platform cautioned investors that its user numbers were unlikely to increase substantially this year when compared with the spike caused by the pandemic.

  • Amazon rose about 1 percent after it reported $108.5 billion in sales in the first three months of the year, up 44 percent from a year earlier. It also posted $8.1 billion in profit, an increase of 220 percent from the same period last year.

  • With the pandemic shifting sales online and consumers flush with stimulus checks, Amazon on Thursday reported $108.5 billion in sales in the first three months of the year, up 44 percent from a year earlier. It also posted $8.1 billion in profit, an increase of 220 percent from the same period last year. The high volume of orders during the pandemic has let Amazon operate more efficiently. It has run its warehouses closer to full capacity, and delivery drivers have made more stops on their routes, with less time driving between customers. The number of items Amazon sold grew 44 percent, but the cost to fulfill those orders was up only 31 percent.

  • Twitter reported on Thursday that its revenue in the first quarter of the year was $1.04 billion, a 28 percent increase from the same quarter the previous year that modestly exceeded analyst expectations. Net income for the quarter was $68 million, a turnaround from an $8.4 million loss in the same quarter a year ago. The banning of former President Donald J. Trump did not appear to have hurt Twitter’s financial performance in the quarter. The company saw a 20 percent jump in daily active users who see ads, to 199 million. It also added new advertising formats, leading to a 32 percent increase in ad revenue in the quarter.

Tesla has been losing market share even as demand for rooftop solar power has grown.Credit…Caleb Kenna for The New York Times

Tesla’s solar ambitions date to 2015 when it announced that it would sell panels and home batteries alongside its electric cars. A year later, Elon Musk, the company’s chief executive, promised that Tesla’s new shingles would turbocharge installations by attracting homeowners who found solar panels ugly.

After delays, Tesla began rolling out the shingles in a big way this year, but it is already encountering a major problem, Ivan Penn reports for The New York Times.

The company is hitting some customers with price increases before installation that are tens of thousands of dollars higher than earlier quotes, angering early adopters and raising big questions about how Tesla, which is better known for its electric cars, is running its once dominant rooftop solar business.

The shingles remain such a tiny segment of the solar market that few industry groups and analysts bother to track installations.

Tesla is not the only company to pursue the idea of embedding solar cells, which convert sunlight into electricity, in shingles. Dow Chemical, CertainTeed, Suntegra and Luma, among others, have offered similar products with limited success.

But given Mr. Musk’s success with Tesla’s electric cars and SpaceX’s rockets, Tesla’s glass shingles attracted outsize attention. He promised that they would be much better than anything anybody else had come up with and come in a variety of styles so they could resemble asphalt, slate and Spanish barrel tiles to fit the aesthetic of each home.

During a quarterly earnings call on Monday, Mr. Musk insisted that demand for Tesla’s solar roofs “remains strong” even though the company had raised prices substantially. He described the last-minute increases as a teething problem.

Customers are unhappy with the growing pains. Dr. Peter Quint was eager to install Tesla’s solar shingles on his 4,000-square-foot home in Portland, Ore., until the company raised the price to $112,000, from $75,000, in a terse email. When he called Tesla for an explanation, he was put on hold for more than three hours.

“I said, ‘This isn’t real, right?’” said Dr. Quint, whose specialty is pediatric critical care. “The price started inching up. We could deal with that. Then this. At that price, in our opinion, it’s highway robbery.”

The average selling price of Ford models rose 8 percent in the first three months of 2021 compared with a year ago, to $47,858, according to the auto-sales data provider Edmunds.com.Credit…Mohamed Sadek for The New York Times

In the first months of 2021, what was good for the auto industry was decidedly good for the American economy.

Spending on motor vehicles and parts rose almost 13 percent in the first quarter, making a big contribution to the increase in gross domestic product, the Commerce Department reported Thursday. Strong sales of new and used vehicles were propelled by consumers who had delayed purchases earlier in the pandemic and by others who — because of the virus — wanted to rely less on public transit or shared transportation services like Uber.

Two rounds of stimulus payments since late December were a big factor. Low interest rates, readily available credit, rising home values and stock prices, and strong trade-in values for used models also eased the path for consumers.

In fact, demand in the first quarter was robust enough that the auto industry was able to post healthy results despite a shortage of computer chips that forced temporary shutdowns of many auto plants.

The number of new cars and light trucks sold increased 11 percent from the comparable period a year earlier, to 3.9 million, according to the auto-sales data provider Edmunds.com.

On Wednesday, Ford Motor reported it made a $3.3 billion profit in the quarter, its highest total since 2011. While it produced 200,000 fewer vehicles in the quarter than it had planned, the average selling price of Ford models rose to $47,858, 8 percent higher than in the first quarter a year ago, Edmunds reported.

The combination of strong consumer demand and tight inventories — partly a result of the chip shortage — has produced something of a dream scenario for auto retailers. At AutoNation, the country’s largest chain of dealerships, many vehicles are being sold near or at sticker price even before they arrive from the factory.

“I’ve never seen so much preselling of shipments,” said Mike Jackson, the chief executive. “These vehicles are coming in and going right out.”

In the first quarter, AutoNation’s revenue jumped 27 percent, to $5.9 billion, and the company reported $239 million in profit. That was a turnaround from a loss a year ago, when the pandemic crimped sales and forced AutoNation to close stores.

Categories
Business

Europe’s financial system is predicted to shrink whereas the U.S.’s grows.

European authorities will release data on Friday that are widely expected to show another economic downturn in the first three months of the year as the ongoing pandemic has led governments to extend lockdowns.

A day after the United States announced that its economy had grown 1.6 percent over the same period – a robust annual rate of 6.4 percent – the expected European contraction shows a contrast of happiness on opposite sides of the Atlantic.

Driven by dramatic public spending to stimulate growth and a rapid surge in vaccination rates, the United States – the world’s largest economy – expanded rapidly in the first few months of 2021. At the same time, the 19 nations that share the euro currency were likely trapped in the second part of a so-called double-dip recession, due to far less aggressive stimulus spending and botched vaccine security efforts.

However, economic growth is a snapshot of the past and the last few weeks have shown encouraging signs that Europe is on the mend. Although Covid-19 is spreading alarmingly in large economies like Germany and France, factories have revived production as more and more people are out and about in cities.

The initial lockdowns last year penalized European economies and brought much of business to a standstill. However, the current restrictions are calibrated to allow a better understanding of the spread of the virus. Instead of closing their doors all the way, restaurants in some countries serve meals on terraces or place take-away orders. Roofers, joiners and other craftsmen have resumed their work as long as they can stay outside.

“We have learned to deal with the pandemic,” said Dhaval Joshi, chief strategist at BCA Research in London. “We adapt.”

Vaccination rates are increasing across Europe, a trend likely to be driven by the recent European Union agreement to secure Pfizer’s doses.

By depriving households of money to spend, the pandemic has resulted in savings – money that can enter businesses when fears of the virus subside.

Most economists and the European Central Bank assume that the euro zone will expand rapidly in the further course of 2021 and achieve growth of more than 4 percent for the year as a whole.

Even in the most hopeful scenario, Europe’s recovery is lagging behind the United States, reflecting their different approaches to economic trauma.

Since last year, the United States has allocated additional public spending equivalent to 25 percent of its national economic output to pandemic-related stimulus programs and aid programs, according to the International Monetary Fund. That is 10 percent in Germany.

But Europe also started the crisis with far more extensive social safety nets programs. As the United States directed cash to those who were pushed back by the pandemic, Europe limited spikes in unemployment.

“Europe has more insurance systems,” said Kjersti Haugland, chief economist at DNB Markets, an Oslo investment bank. “You don’t fall as hard, but you also don’t bounce off as hard.”

Categories
Health

Covid ‘risk stays current’ WHO says at the same time as Europe’s circumstances decline

A boy reacts next to the body of his father, who died of coronavirus disease (COVID-19), in a crematorium in New Delhi, India, on April 24, 2021.

Adnan Abidi | Reuters

LONDON – The threat to Europe from the coronavirus “remains,” the World Health Organization said Thursday, despite the recent drop in new cases, hospitalizations and deaths in the region.

“It has been 462 days since the first Covid-19 cases were reported. Based on the number of confirmed cases, 5.5% of the total European population had Covid-19, while 7% completed a full series of vaccinations,” he said WHO Regional Director for Europe, said Dr. Hans Kluge in a press conference on Thursday.

“But even if new cases, hospital stays and deaths decrease, the threat remains,” warned Kluge.

The virus still has the potential to wreak havoc, he added, noting that almost half of all reported infections in Europe since the pandemic began actually occurred in the first four months of this year.

However, as a sign of hope for the region, he added that “for the first time in two months, new cases fell significantly last week. Nevertheless, infection rates in the region remain extremely high.”

The comments are found amid a mixed picture of recovery around the world. As India grapples with a devastating surge in cases and a lack of medical care, other parts of the world are starting to reopen their economies.

In Europe, the UK is steadily lifting its lockdown and the introduction of vaccinations is progressing rapidly. To date, nearly 34 million adults in the country have received a first dose of a coronavirus vaccine, and over 13 million people have had two doses, government data shows.

In mainland Europe, according to the European Center for Disease Control and Prevention, over 133 million doses of Covid vaccines have been administered in 30 countries in the European Economic Area (EU plus Iceland, Liechtenstein and Norway).

The speed of vaccination programs varies widely across the EU, with some countries advancing faster than others.

WHO’s Kluge called on governments not to allow vaccination programs, public engagement for vaccines, or surveillance of the virus.

“Where vaccination rates are highest in high-risk groups, hospital admissions and death rates fall. Vaccines save lives, and they will change the course of this pandemic and ultimately help end it,” he said.

“We also need to be aware of the fact that vaccines alone will not end the pandemic.” Without informing and involving the communities, they remain exposed to the virus. Without monitoring, we cannot identify any new variants. And without tracing, governments may have to reintroduce restrictive measures. “

Categories
Business

Europe’s altering guidelines prompts confusion

LONDON – There are signs that the different – and changing – rules of use in Europe regarding the coronavirus vaccine developed by AstraZeneca and Oxford University are creating further confusion and suspicion among citizens.

Not only have EU citizens faced a barrage of negative sentiment towards the vaccine, even from top officials themselves, but they have seen the shot suspended by more than a dozen European countries after concerns about a small number of blood reports clots became loud.

The European Medicines Agency and World Health Organization, after safety reviews of the data, recommended continued use of the shot, saying its benefits outweighed the possible risks. But those fears have not gone away and there is now confusion about which age group should and can take the vaccine.

On Tuesday, Germany stopped using the AstraZeneca shot on all citizens under 60, citing renewed concerns after a small number of reports of rare but serious blood clots. Earlier this week, some hospitals in Berlin initially stopped vaccinating women under the age of 55 with AstraZeneca’s shot.

Germany initially only allowed the vaccine to be used under 65 years of age due to insufficient data to show that it was safe and effective for the elderly, despite reversing that decision in early March.

Meanwhile, Spain decided on Wednesday to extend the use of the vaccine to key workers over 65 years of age. The vaccine was previously limited to the 55 to 65 age group, but is now made available to priority groups in this age group such as health workers, police officers and teachers.

In France, the AstraZeneca vaccine was initially not approved even for people over 65 years of age. French President Emmanuel Macron has now been criticized by many French commentators for his chair epidemiology, falsely saying that the vaccine is “virtually ineffective” for those over 65.

France later reversed that stance when more clinical trial data emerged, saying the vaccine would be approved for people with comorbidities, including those between the ages of 65 and 74.

Confused? You’re not alone. Comments on Twitter indicate that people on both sides are confused about the official stance on the vaccine.

A Twitter user based in Germany noted that “you can’t blame people for confusion” after listing the twists and turns that characterized AstraZeneca’s vaccine timeline.

Another user, Aetera, based in Germany, noted that “everyone here is confused whether it is good or bad” while another UK Twitter user, Mike Carrivick, said the reverse of the rules of use around the vaccine was going on the “irony of irony”, but one with potentially serious consequences. He remarked, “No wonder so many are confused and lives in danger.”

London-based Kristen Covo was another Twitter user who expressed confusion over AstraZeneca’s safety data after being suspended in a handful of European countries and resuming use following recommendations from the EMA and WHO.

Regarding the question of giving the second dose of vaccine to younger people who have already received a first dose of the AstraZeneca vaccine, the German vaccine committee announced that it would issue guidelines on the matter by the end of April.

The ambivalent and changing attitudes of European countries towards the vaccine were made all the more confusing by an accompanying narrative (and major argument) about the delivery of the shot.

The EU has repeatedly accused the drug maker of failing to meet its delivery schedule, while various EU officials and heads of state and government have cast doubts about the vaccine’s effectiveness, which in turn has made many EU citizens skeptical about vaccines.

A Brussels-based BBC reporter noted that it had been dubbed the “Aldi vaccine” after the cheap grocery store because people viewed the shot as a budget option. There have been other reports from people requesting Pfizer BioNTech or Moderna shots instead of the AstraZeneca vaccine.

As an English Twitter user named gazztrade asked on Wednesday, does the EU want “the AstraZeneca vaccine or not”?

Categories
Health

Europe’s third coronavirus wave has arrived

Traffic runs along the Champs-Elysee avenue near the Arc de Triomph in Paris, France on Friday March 19, 2021. French President Emmanuel Macron lockdowns several regions, including the Paris area, and slows the country’s economic recovery as it battles to contain a third wave of the coronavirus epidemic. Photographer: Cyril Marcilhacy / Bloomberg via Getty Images

Bloomberg | Bloomberg | Getty Images

LONDON – Warnings of an exponential increase in infections in Germany and another month-long lockdown in Paris have underscored the dire situation across Europe as the coronavirus rises again.

The variant first discovered in Great Britain is seen as the reason for the new tip. The strain is reported to be much more virulent than the original.

The French capital and the northern parts of the country will be locked again on Friday, although schools and important shops remain open.

The seven-day average of new coronavirus cases in the country rose to over 25,000 this week for the first time since November.

In Germany, Chancellor Angela Merkel announced a loosening of the locks in March. At that point, the number of infections per 100,000 people over seven days was 65.

But that number is now at 96 and there are real fears that infections at Easter might mirror what they were at Christmas.

“The increasing number of cases could mean that we will not be able to take any further opening steps in the coming weeks,” said Federal Health Minister Jens Spahn at a press conference on Friday, according to Reuters.

“On the contrary, we may even have to go backwards.”

In Poland, according to Reuters, there was also a huge increase in infections with around 52% of new cases related to the variant from Great Britain.

The total number of cases for the country that was advanced was 2 million as of Friday, 25,998 in the last 24 hours.

– CNBC’s Bryn Bache contributed to this article.

Categories
Health

Europe’s suspension of AstraZeneca’s Covid vaccine is damaging

LONDON – The decision of many European countries to stop using the Oxford-AstraZeneca University coronavirus shot could have far-reaching ramifications, analysts say, as vaccine uptake and the wider vaccination program are already lagging behind in the region.

Sweden and Latvia were the last countries to stop using the Oxford-AstraZeneca vaccine on Tuesday over concerns about blood clots. The move follows, among others, Germany, France, Spain, Italy and Ireland to temporarily suspend use of the vaccine as a precautionary measure, while assessing whether there is a connection between the shot and an increased risk of blood clots.

The World Health Organization, drug regulators, and the vaccine maker itself have tried to downplay persistent safety concerns. There is currently no evidence to suggest that there is a link between the shot and an increased risk of developing blood clots, which are common in the general population.

In particular, the WHO has asked the countries not to pause with the shot in their vaccination rollouts. The Advisory Committee on Vaccine Safety has checked the available data and is in close contact with the EU Medicines Agency, the European Medicines Agency.

Additional expert guidance is expected to be announced shortly after the security reviews: the WHO Security Committee will meet on Tuesday, while the EMA will meet on Thursday.

EMA Executive Director Emer Cooke said in a news conference on Tuesday that EU member states’ decision to suspend use of the vaccine could result in lower public confidence in the shot, which affects vaccines confidence, but our job is to make sure that the products we approve are safe. “

It’s not the first time Oxford-AstraZeneca’s vaccine has come under pressure as the drug maker was previously asked about its testing method and data, the effectiveness of the shot in those over 65, and a publicized dispute with the EU Delivery of supplies to the block.

However, health experts and policy analysts are questioning whether much of Europe’s decision to suspend use of the AstraZeneca shot is misplaced and is likely to further damage or even cost lives confidence in the vaccine if a third wave of infections is observed is Paris to Prague, and the introduction of shots by the EU is already slow.

“At this stage, national regulators are likely to act conservatively and out of caution. A risk-averse approach will help reassure the public and limit the impact on future adoption. But the prospect of a longer review or an outright ban cannot be ruled out, “said Federico Santi, Senior Europe Analyst at Eurasia Group, in a statement on Monday.

“Either way, the damage has been done. Willingness to take the AstraZeneca vaccine has already been lower than that of mRNA vaccines available in the EU, as the effectiveness of the headlines and initial confusion about its suitability for those over 65 years of age initially began were confused, “he said.

Some wonder if there was a political element behind the decision to pause the vaccine, as there have been disputes about it in the past.

Several European countries initially decided not to recommend the vaccine for people over 65 as there wasn’t enough evidence that it was effective before reversing that decision as more data became available showing it was the number severe Covid infections and hospital stays were highly effective in reducing deaths.

Such decisions, which were not supported by derogatory remarks from some European heads of state and government (French President Emmanuel Macron once said the vaccine was “virtually ineffective” for those over 65), were viewed by some Europeans only as reluctant to Oxford -AstraZeneca viewed vaccine. The introduction of vaccination in the EU is already much slower than in the UK and US, and the bloc leadership has come under fire for its vaccination strategy.

“We know where this is going, it will lead to a loss of confidence in the vaccine,” Natasha Loder, health policy editor for The Economist, told the BBC’s “Today” program on Tuesday.

When asked whether the suspension had a political dimension, Loder said, “It could be that this vaccine feels bad.” Nevertheless, the decision has “no rational basis” and could be dangerous. “This precautionary principle is nonsense when you are in the middle of a pandemic,” Loder said.

“This is a safe vaccine and when they realize that this is a safe vaccine in Europe they will have to face the aftermath of all this media coverage.”

However, not all EU countries are following the same path. Belgium, Poland and the Czech Republic say they will continue to use the shot, saying the benefits outweigh the risks.

AstraZeneca has vigorously defended its vaccine, stating in a statement Sunday that the number of blood clots recorded after vaccination was fewer than would naturally be expected.

Categories
Health

Coronavirus anniversary: Europe’s gradual vaccine rollout

On Tuesday, January 12, 2021, a health care worker will take care of a Covid 19 patient in the intensive care unit of the Robert Bosch Hospital in Stuttgart. Chancellor Angela Merkel warned that Germany would face tough lockdown measures until the end of March if the authorities do not contain a rapidly spreading variant of the coronavirus.

Bloomberg | Bloomberg | Getty Images

It’s been a year since the World Health Organization declared the coronavirus outbreak a pandemic, and as the UK and US progress with their vaccination rollouts, the EU is still in the depths of crisis.

The block is currently in a lethargic vaccination program and there are fears of another wave of infections from Paris to Prague.

On the first anniversary of the public health crisis, Europe doesn’t have much time to ponder the losses of the past year – when over 547,000 people in the region died from the virus and thousands lost their livelihoods.

There are more and more cases in parts of the bloc, mainly caused by the spread of more infectious virus variants, from western EU country France to Central Europe to Hungary in the east.

France reported 30,303 new coronavirus infections in the past 24 hours on Wednesday, with the number of new cases rising above 30,000 for the first time in two weeks. Health experts say the hospital system in the greater Paris area is on the verge of rupture, Reuters reported.

Meanwhile, Hungary, the Czech Republic and Poland have seen large increases in cases, which has led Eastern European governments to increase vaccination rates. So much so that several countries have resorted to a break with the EU with the approval of the Russian coronavirus vaccine Sputnik V, which has not yet been approved by the EU drug regulator.

Bulgaria and Serbia, as well as Sweden and Italy, are also among the countries where there has been an increase in cases.

The coronavirus, which first appeared in Wuhan in December 2019, was declared a pandemic a year ago, on March 11, 2020.

At this point it had already formed in northern Italy, which became the epicenter of Europe’s first eruption. The timing of the spread coincided with the peak of the ski season, allowing the virus to spread to the UK, France and Germany.

The EU’s Covid Experience

National responses to the pandemic have varied, but the EU tried to coordinate its response, closing external borders for all but non-essential travel, and coordinating purchases of personal protective equipment and medical supplies such as ventilators.

However, the state and structure of health services in different parts of the EU, as well as the tracking and tracing systems in place, played a role in determining the spread and damage caused by the virus.

Germany, for example, has been praised for its initial response to the virus, in which the infected and their contacts were tracked down and isolated. Modern hospital infrastructure has also helped limit the number of deaths compared to other countries. Germany (with around 83 million inhabitants) has so far reported 2.5 million cases and 72,858 deaths compared to Italy (a country of 60.3 million people), 3.1 million cases and 100,811 deaths, according to data from Johns Hopkins University.

In total, according to the European Center for Disease Control and Prevention in the EU and in the entire European Economic Area (essentially in the EU plus Iceland, Liechtenstein and Norway), over 22.5 million cases have been reported so far.

The extent to which countries blocked their economies and public life during the pandemic also had an impact on infection rates.

Most of the countries in the EU chose to close all shops but the main ones, to close gyms, restaurants, theaters and bars, and to close the region’s cultural and social life and economy. Although some, like Sweden, were notable for their decision not to lock, they sparked controversy and criticism from other EU countries, especially their neighbors.

However, it has gradually moved away from that position, especially in the face of a third wave of infections, and stricter restrictions on shops, gyms, swimming pools and sports facilities went into effect on March 6.

Economic damage

Economies across the bloc are hoping to open up as soon as possible, but the emergence of new, more virulent strains of the virus has ruined Christmas, ski season, and hopes that life could return to normal by Easter.

At the same time, vaccination adoption across the bloc remains painfully slow compared to the UK and US

The latest data from France shows that by March 9, 4.1 million people had received an initial coronavirus vaccine. In contrast, the UK had given over 22.8 million first doses at the same time.

The UK ordered, approved and administered vaccines faster than the EU, which placed orders in blocks rather than following individual guidelines. This was seen as an obstacle to the dynamics of the rollout.

The economic damage from the pandemic cannot be counted yet, but repeated lockdowns over the past year have taken their toll. A feared new wave could also delay a long-awaited reopening.

Data shows the damage the pandemic has already done to the region’s economy and citizens. Preliminary data from Eurostat, the EU data agency published in February, estimate that GDP (gross domestic product) fell by 6.8% in 2020 in the euro area and by 6.4% in the EU.

Eurostat estimates that 15.6 million men and women were unemployed in the EU in January 2021. Compared to January 2020, unemployment rose by 1.465 million in the EU and 1.010 million in the euro area.